Skip to content

A post market clinical follow-up study with the short stem uncemented endoprosthesis (optimys) BMI > 40

A post market clinical follow-up study with the short stem uncemented endoprosthesis (optimys) BMI > 40

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00014719
Enrollment
50
Registered
2018-05-04
Start date
2017-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16.1 M16.7

Interventions

Group 1: Total hip endoprosthesis with an optimys shaft, at a BMI over 40. Clinical and radiographic follow-up is performed after 6-12 weeks, 12, 24, 60 months.

Sponsors

Mathys Orthopädie GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The patient must: • have a BMI over 40 • the patient must sign his written consent • Primary implantation • suffer from primary or secondary coxarthrosis of the femoral head • Fractures or necrosis of the femoral head in these cases, a stable anchoring of the implant must be possible • Age at inclusion: between 18 and 75 years • Willingness to participate in the above-mentioned follow-up examinations

Exclusion criteria

Exclusion criteria: The patient is not allowed to: • have a known or suspected addiction (eg, drug or alcohol abuse) • Inclusion of the study doctor, his family, employees or other dependent persons • Missing consent form (not signed by the participant and / or the study doctor) • Patients younger than 18 years • Revision operations • Presence of sepsis or malignant tumor / tumors • femoral fractures • No dysplasia with a sharp femoral neck • ASA classification <3 • Pregnancy

Design outcomes

Primary

MeasureTime frame
After 5 years, the following shall also be measured and evaluated: • A retrospective analysis of the X-rays using EBRA-FCA for the evaluation of the stem migration. • According to the evaluation of the Gruen Zones early loosening of the implants should be detected as soon as possible and evaluated. • Systematic collection of possible complications.

Secondary

MeasureTime frame
The Harris Hip Score (HHS) and the SF36 are the secondary final point of the study. The follow-ups shall be performed after 6–12 weeks, 1 year, 2 years and 5 years.

Countries

Germany

Contacts

Public ContactNatividad Zeleny

Mathys Orthopädie GmbH

natividad.zeleny@mathysmedical.de+49 170 572 2702

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026